{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-051f54-2026-03-12T14:51:32Z", "date": "2026-03-12T14:51:32Z", "ocid": "ocds-h6vhtk-051f54", "initiationType": "tender", "parties": [ { "id": "GB-COH-08493132", "name": "GENOMICS ENGLAND LIMITED", "identifier": { "scheme": "GB-COH", "id": "08493132" }, "address": { "streetAddress": "Level 21 One Canada Square", "locality": "London", "postalCode": "E14 5AB", "country": "GB", "countryName": "United Kingdom", "region": "UKI42" }, "contactPoint": { "email": "procurement@genomicsengland.co.uk", "name": "Paul Nicholson" }, "roles": [ "buyer" ], "details": { "url": "http://www.genomicsengland.co.uk", "classifications": [ { "id": "publicAuthorityCentralGovernment", "scheme": "UK_CA_TYPE", "description": "Public authority - central government" } ] }, "additionalIdentifiers": [ { "scheme": "GB-PPON", "id": "PBTW-5897-QJGY" } ] }, { "id": "GB-PPON-PWGW-8642-PVGJ", "name": "Verily Life Sciences", "identifier": { "scheme": "GB-PPON", "id": "PWGW-8642-PVGJ" }, "address": { "streetAddress": "251 Little Falls Drive", "locality": "Wilmington, Delaware", "postalCode": "19808", "country": "US", "countryName": "United States", "region": "US" }, "roles": [ "tenderer" ], "details": { "url": "https://verily.com/", "scale": "large", "vcse": false } }, { "id": "GB-COH-10727859", "name": "LIFEBIT BIOTECH LIMITED", "identifier": { "scheme": "GB-COH", "id": "10727859" }, "additionalIdentifiers": [ { "scheme": "GB-PPON", "id": "PRZN-4937-WCYN" } ], "address": { "streetAddress": "3rd Floor Suite 207 Regent Street", "locality": "London", "postalCode": "W1B 3HH", "country": "GB", "countryName": "United Kingdom", "region": "UKI32" }, "contactPoint": { "email": "procurement@lifebit.ai" }, "roles": [ "supplier", "tenderer" ], "details": { "url": "https://www.lifebit.ai/", "scale": "sme", "vcse": false, "publicServiceMissionOrganization": false, "shelteredWorkshop": false } } ], "buyer": { "id": "GB-COH-08493132", "name": "GENOMICS ENGLAND LIMITED" }, "tender": { "id": "GEL-RE-812-24", "legalBasis": { "id": "2023/54", "scheme": "UKPGA", "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents" }, "title": "Genomics England Researcher Platform", "description": "Genomics England's vision is for a world where everyone benefits from genomic healthcare. To achieve this, we play the role of the national data and evidence engine for genomics in healthcare, research and innovation. The Researcher Platform we are contracting for plays a critical role in this, hosting the National Genomic Research Library (NGRL) and enabling researchers to safely use and access the data we hold. Genomics England manages the National Genomics Research Library (NGRL), a large repository of genomic data collected in collaboration with the NHS. As one of the largest data assets of its kind, the NGRL plays a crucial role in advancing genomic research and healthcare innovation. It includes data from the NHS and from various other studies in humans. The NGRL currently holds data for circa 135,000 participants encompassing circa 168,000 genomes and other associated data such as clinical records, diagnostic findings, images and multi-omics profiles. We anticipate this number could exceed 500,000 genomes by 2030. The procurement and subsequent contract for the Researcher Platform requirement was driven by our commitment to serving Users. We aim to provide a secure, user-friendly platform that caters to varying technical abilities, ensuring that all users can effectively analyse data. This means a platform with an optimal set of tools and capabilities to be leveraged to cater for these many varying needs and collaborating with a mature partner that is willing to follow and implement the innovations that can improve user experience and research output. The partnership will develop, test, deploy, and support a Researcher Platform for a minimum of 600 Monthly Active Users rising to 2000 Monthly Active Users by the end of of the Contract Term. The expected contract signature date is end of April 2026, and the expected implementation period is up to 9 months. The Initial Term of the contract from the Service Commencement Date (post implementation) will be three years, with the opportunity to extend for two periods of 1 year, making the total possible Contract Term five years from the Service Commencement Date.", "status": "complete", "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "48517000", "description": "IT software package" }, { "scheme": "CPV", "id": "72222300", "description": "Information technology services" }, { "scheme": "CPV", "id": "72261000", "description": "Software support services" }, { "scheme": "CPV", "id": "72262000", "description": "Software development services" }, { "scheme": "CPV", "id": "72263000", "description": "Software implementation services" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "value": { "amountGross": 17280000, "amount": 14400000, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Competitive flexible procedure", "procedure": { "features": "The market engagement for this requirement started under PCR15 and can be accessed at the following address https://www.find-tender.service.gov.uk/Notice/024170-2024. This will be a three-stage procurement process, with a fourth contract finalisation stage. Further details on the process are set out in the ITT document. Stage One (CoP and Initial Tenders): Tenderers are invited to respond to an Invitation to Tender. The ITT document contains instructions regarding the response and completion of the Conditions of Participation response (Project Procurement Specific Questionnaire) and instructions for the submission of Initial Tenders. It also includes the Specification, the Draft Contract and other information regarding the Procurement Process. Tenderers must submit their completed PSQ and Initial Tenders in accordance with the ITT. PSQ's shall be assessed against the Conditions of Participation and the Initial Tenders shall then be evaluated in accordance with the Award Criteria set out in the ITT. The three highest ranking Tenderers shall be invited to the Dialogue Stage. Stage Two (Dialogue Stage): Following receipt of an invitation from the Authority, the Authority will enter into dialogue with each selected Tenderer to discuss their Initial Tender. Dialogue with the selected Tenderers will continue until the Authority is satisfied that one or more of the proposals received will meet its requirements and include all elements required and necessary for the performance of the Contract, or until the Authority concludes, in the case of any Tenderer, that it does not wish to continue dialogue. At the end of these sessions, the Authority will formally declare that dialogue has concluded and will request Final Tenders. Stage Three (Invitation to Submit Final Tenders (ITSFT)): Following dialogue, Final Tenders shall be requested and submitted by Tenderers in response to the ITSFT." }, "mainProcurementCategory": "services", "aboveThreshold": true, "coveredBy": [ "GPA", "CPTPP" ], "submissionMethodDetails": "Tenders must be submitted electronically via the e-tendering portal https://genomicsengland.bravosolution.co.uk", "submissionTerms": { "electronicSubmissionPolicy": "allowed", "languages": [ "en" ] }, "tenderPeriod": { "endDate": "2025-07-18T12:00:00+01:00" }, "enquiryPeriod": { "endDate": "2025-06-27T17:00:00+01:00" }, "awardPeriod": { "endDate": "2026-02-13T23:59:59+00:00" }, "lots": [ { "id": "1", "status": "complete", "value": { "amountGross": 17280000, "amount": 14400000, "currency": "GBP" }, "awardCriteria": { "criteria": [ { "type": "price", "name": "Price", "description": "The lowest sustainable indicative total price will be given 100% of the price weighting, with other Tenders expressed as an inverse proportion of the lowest price. This will produce the total weighted price scores. Lowest sustainable indicative total price / Tender Price x % weighting = weighted price score", "numbers": [ { "number": 20, "weight": "percentageExact" } ] }, { "type": "quality", "name": "Quality", "description": "The Quality score will be made up of a number of questions relating to sub-criteria, namely: Researcher core functionality; Machine learning functionality; Keep pace with emerging needs; Integration and compatibility with tools and systems; Performance and scalability; Security compliance; Implementation; Test Management; Service delivery, including user management, training and support; User experience practices; Performance management; and Non-mandatory functional requirements. There will be a pass/fail element covering mandatory functional requirements. Draft Contract Criteria - Note that Tenderers are required to complete ITT Schedule 8 (Tender Response Document - Contract) as part of their submission over and above both the Quality Criteria and the Social Value Criteria. This ITT Schedule 8 document specifies which parts of the Draft Contract must be accepted to meet the mandatory Requirements and which elements that the Tenderer is permitted to mark up and provide their reasons for doing so (though please be aware that the Authority does not intend to negotiate the Draft Contract and the expectation is that Tenderers accept it). Tenderer's responses to the Draft Contract shall be scored in accordance with the scoring table set out in the ITT. The score shall translate into a potential deduction of a maximum of 5% from the Tenderers initial total score for Quality, Social Value and Price depending upon the outcome of the Contract Evaluation as set out in the tender documents.", "numbers": [ { "number": 70, "weight": "percentageExact" } ] }, { "type": "quality", "name": "Social Value", "description": "The social value element will cover the themes of Sustainable Procurement Practices (Policy Outcome 4) and Increasing productivity through physical and mental wellbeing (Policy Outcome 8).", "numbers": [ { "number": 10, "weight": "percentageExact" } ] } ] }, "selectionCriteria": { "criteria": [ { "type": "economic", "description": "As described in ITT and its Appendix 1 - Procurement Specific Questionnaire." }, { "type": "technical", "description": "As described in ITT and its Appendix 1 - Procurement Specific Questionnaire." } ] }, "suitability": { "sme": true }, "contractPeriod": { "startDate": "2026-04-01T00:00:00+01:00", "endDate": "2030-02-01T23:59:59+00:00", "maxExtentDate": "2032-01-31T23:59:59+00:00" }, "hasRenewal": true, "renewal": { "description": "The Authority will be entitled at its absolute discretion to extend the Contract Term on the same terms and conditions for a further period or periods of up to a total extension period totalling 2 years form the original contract end date." } } ], "documents": [ { "id": "conflictOfInterest", "documentType": "conflictOfInterest", "description": "Not published" }, { "id": "025343-2025", "documentType": "tenderNotice", "noticeType": "UK4", "description": "Tender notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/025343-2025", "datePublished": "2025-05-22T17:25:19+01:00", "format": "text/html" } ], "contractTerms": { "financialTerms": "A Supplier invoice will only be valid if it includes: the minimum required information set out in Section 68(9) of the Procurement Act 2023; all appropriate references including the Contract reference number and other details reasonably requested by the Buyer; the purchase order number provided by the Buyer; and a detailed breakdown of Delivered Services and Milestone(s) (if any). Further details on invoicing and disputed invoices are set out in the draft contract accompanying the ITT." } }, "language": "en", "bids": { "details": [ { "id": "1", "status": "valid", "tenderers": [ { "id": "GB-COH-10727859", "name": "LIFEBIT BIOTECH LIMITED" } ], "relatedLots": [ "1" ] }, { "id": "2", "status": "valid", "tenderers": [ { "id": "GB-PPON-PWGW-8642-PVGJ", "name": "Verily Life Sciences" } ], "relatedLots": [ "1" ] } ], "statistics": [ { "id": "1", "measure": "bids", "value": 9, "relatedLot": "1" }, { "id": "2", "measure": "finalStageBids", "value": 2, "relatedLot": "1" }, { "id": "3", "measure": "smeFinalStageBids", "value": 1, "relatedLot": "1" }, { "id": "4", "measure": "vcseFinalStageBids", "value": 0, "relatedLot": "1" } ] }, "awards": [ { "id": "1", "title": "Genomics England Researcher Platform", "status": "pending", "date": "2026-03-12T00:00:00Z", "value": { "amountGross": 23400000, "amount": 19500000, "currency": "GBP" }, "mainProcurementCategory": "services", "aboveThreshold": true, "suppliers": [ { "id": "GB-COH-10727859", "name": "LIFEBIT BIOTECH LIMITED" } ], "items": [ { "id": "1", "additionalClassifications": [ { "scheme": "CPV", "id": "48100000", "description": "Industry specific software package" }, { "scheme": "CPV", "id": "72000000", "description": "IT services: consulting, software development, Internet and support" } ], "deliveryAddresses": [ { "region": "UK", "country": "GB", "countryName": "United Kingdom" } ], "relatedLot": "1" } ], "standstillPeriod": { "endDate": "2026-03-24T23:59:59+00:00" }, "contractPeriod": { "startDate": "2026-05-01T00:00:00+01:00", "endDate": "2030-01-31T23:59:59Z", "maxExtentDate": "2032-01-31T23:59:59Z" }, "hasRenewal": true, "renewal": { "description": "The Contract can be extended in two periods of 1 year following the Initial Term of 3 years from the Service Commencement Date. It is anticipated the Service Commencement Date will be 9 months after Contract Signature estomated to be end of April 2026." }, "hasOptions": true, "options": { "description": "Optional development of Billing functionality" }, "relatedLots": [ "1" ], "documents": [ { "id": "022407-2026", "documentType": "awardNotice", "noticeType": "UK6", "description": "Contract award notice on Find a Tender", "url": "https://www.find-tender.service.gov.uk/Notice/022407-2026", "datePublished": "2026-03-12T14:51:32Z", "format": "text/html" } ], "assessmentSummariesDateSent": "2026-03-12T00:00:00Z", "milestones": [ { "id": "1", "type": "futureSignatureDate", "dueDate": "2026-04-30T23:59:59+01:00", "status": "scheduled" } ] } ] }